Anti-matrix metalloproteinase-9 DNAzyme decreases tumor growth in the MMTV-PyMT mouse model of breast cancer.
about
Genetically engineered mice as experimental tools to dissect the critical events in breast cancerProtein arginine methyltransferase 7 promotes breast cancer cell invasion through the induction of MMP9 expressionTreatment of multifocal breast cancer by systemic delivery of dual-targeted adeno-associated viral vectors.DDMC-p53 gene therapy with or without cisplatin and microwave ablation.Effects of methylglyoxal and glyoxalase I inhibition on breast cancer cells proliferation, invasion, and apoptosis through modulation of MAPKs, MMP9, and Bcl-2.Anti-insulin-like growth factor-IIP3 DNAzymes inhibit cell proliferation and induce caspase-dependent apoptosis in human hepatocarcinoma cell linesThe distribution, clearance, and safety of an anti-MMP-9 DNAzyme in normal and MMTV-PyMT transgenic mice.Proteolysis-a characteristic of tumor-initiating cells in murine metastatic breast cancer.EGFR expression is associated with cytoplasmic staining of CXCR4 and predicts poor prognosis in triple-negative breast carcinomas.Metastasis review: from bench to bedside.Therapeutic potential of siRNA and DNAzymes in cancer.DNA enzymes as potential therapeutics: towards clinical application of 10-23 DNAzymes.Intratumoral gene therapy versus intravenous gene therapy for distant metastasis control with 2-diethylaminoethyl-dextran methyl methacrylate copolymer non-viral vector-p53.Enhancing the pharmacokinetic/pharmacodynamic properties of therapeutic nucleotides using lipid nanoparticle systems.DNAzyme-based therapeutics for cancer treatment.Delivery of therapeutic RNA-cleaving oligodeoxyribonucleotides (deoxyribozymes): from cell culture studies to clinical trials.Astrocytes promote progression of breast cancer metastases to the brain via a KISS1-mediated autophagy.
P2860
Q35146602-0406B180-92B7-421C-B2B0-98F86C00BD7EQ35550160-72CE8378-064C-447C-A73F-183E006E9545Q35649591-B63F4F07-2E62-4877-869E-C687928A098AQ35654976-842CF13B-41C1-4E5F-AB50-2E695A50358EQ36844345-62AEDCDA-030F-40C4-B1B1-497929E732FFQ37222630-E72B1E24-A2FA-4442-B797-A441D9ED0CE8Q37404297-FFA21009-EC9C-4AE3-96CE-7677F35CB611Q37629015-E9FB55E9-8A17-43C6-B0B1-473394A48415Q37701050-CA582F39-5606-43E6-8036-F4034EBDE5DEQ38237985-6249BF62-3E0E-45FC-8E23-95A91BB25B56Q38242397-2F7392D4-5366-4255-A733-8E43B5F7D11DQ38378692-4051B91E-6B36-4118-89E8-2F33377571ACQ38451785-974F93FA-5FFC-4973-8EBC-F8B15DFB010DQ38591825-5E8037D8-1E81-4B69-9BDB-ECF6838E7ADFQ38962770-8966F9C9-2CB2-4733-B833-83972CA43B10Q39021948-47EA1BEA-145B-4BA5-9C1A-25411B096207Q47693087-83365C26-1207-42B5-AEB3-D394D5FFFF33
P2860
Anti-matrix metalloproteinase-9 DNAzyme decreases tumor growth in the MMTV-PyMT mouse model of breast cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Anti-matrix metalloproteinase- ...... mouse model of breast cancer.
@en
type
label
Anti-matrix metalloproteinase- ...... mouse model of breast cancer.
@en
prefLabel
Anti-matrix metalloproteinase- ...... mouse model of breast cancer.
@en
P2093
P2860
P356
P1476
Anti-matrix metalloproteinase- ...... mouse model of breast cancer.
@en
P2093
Hisashi Hasegawa
Luciana P Schwab
Miranda A Hallett
Tayebeh Pourmotabbed
Tiffany N Seagroves
P2860
P2888
P356
10.1186/BCR3385
P577
2013-02-13T00:00:00Z
P5875
P6179
1043337915